Eric BARAT

Dr. Eric BARAT

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
EBEric BARAT
Eric BARAT
CCCatherine Chenailler
Catherine Chenailler
AGAndré Gillibert
André Gillibert
SPSophie Pouplin
Sophie Pouplin
RVRemi Varin
Remi Varin
VCVincent Compere
Vincent Compere
Post-operative pain is a common symptom of ambulatory surgery. The objective of this study was to evaluate a pain management protocol integrating a pharmacist consultation. We conducted a quasi-experimental, single center, before-after study. The control group was recruited between 1 March and 31 May 2018 and the intervention group between 1 March and 31 May 2019. Outpatients in the intervention group received a pharmacist consultation, in addition to the usual anesthesiologist and nurse consultations. Pharmacist consultations were conducted in two steps: the first step consisted of general open-ended questions and the second step of a specific and individualized pharmaceutical interview. A total of 125 outpatients were included in each group. There were 17% (95% CI 5 to 27%, p = 0.022) fewer patients with moderate to severe pain in the pharmaceutical intervention group compared with the control group, which corresponded to a decrease in the mean pain level of 0.9/10 (95% CI −1.5/10; −0.3/10; p = 0.002). The multivariate analysis did not reveal any confounding factors, showing that only the pharmaceutical intervention could explain this result. This study demonstrates a positive impact of pharmacist consultations on postoperative pain in ambulatory surgery.

23 July 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
EBEric BARAT
Eric BARAT
ASAnnaelle Soubieux
Annaelle Soubieux
PBPauline Brevet
Pauline Brevet
BGBaptiste Gerard
Baptiste Gerard
OVOlivier Vittecoq
Olivier Vittecoq
CLClaire Lattard
Claire Lattard
This is a systematic literature review on the impact of pharmacists in rheumatology, conducted using the PubMed®, CINAHL®, Cochrane Library®, and Web of science® databases and using the PRISMA 2020 checklist. This review was conducted from 2000 to June 2024. A quality analysis was performed. The selection of articles, as well as all analyses, including quality analyses, were conducted by a pair of pharmacists with experience in rheumatology, and included 24 articles. This study highlights the growth of clinical pharmacy activities in rheumatology and the positive influence of clinical pharmacists on patient care. The implementation of such initiatives has the potential to improve medication adherence, reduce medication-related risks, and optimize associated healthcare costs. All these pharmaceutical interventions aim to make the patient care journey smoother and safer. Additionally, the diversity of available pharmaceutical services caters to the varied needs of rheumatology. Furthermore, outpatient clinical pharmacy is also explored in this field and garners interest from patients. The vast majority of studies demonstrate significant improvement in patient care with promising performance outcomes when pharmacists are involved. This review highlights the diverse range of interventions by clinical pharmacists in rheumatology, which is very promising. However, to better assess the benefits of clinical pharmacists, this activity needs further development and evaluation through controlled and randomized clinical research programs.

16 December 2023 in Therapies
Verified
Journal Article
Closed access
EBEric BARAT
Eric BARAT
CPCamille Pouant
Camille Pouant
ASAnnaelle Soubieux
Annaelle Soubieux
MAMarianne Arrii
Marianne Arrii
JBJean-Didier Bardet
Jean-Didier Bardet
RVRémi Varin
Rémi Varin

11 October 2023 in The Breast
Verified
Journal Article
Open access
EBEric BARAT
Eric BARAT
MAMarianne L.E. Arrii
Marianne L.E. Arrii
ASAnnaelle Soubieux-Bourbon
Annaelle Soubieux-Bourbon
MDMikaël Daouphars
Mikaël Daouphars
RVRémi Varin
Rémi Varin
PTPatrick R. Tilleul
Patrick R. Tilleul
Introduction: Subcutaneous (SC) drug administration, such as the Herceptin (R) in an oncology day hospital reduces the administration time of trastuzumab. In the context of combination therapy administration, this time-saving may be called into question. The challenge posed by the deployment of much less expensive IV biosimilar forms raises questions about the cost-effectiveness of SC administration. Methods: Using data from a french Diagnostic Related Groups regarding prescriptions of intravenous Herceptin (R) (HIV), Herceptin (R) biosimilar IV (BSIV), and Herceptin (R) subcutaneous (HSC), we conducted two simulations. This simulation involved replacing all HSC with BSIV in combination therapy administration (Simulation 1) and subsequently substituting IV forms with SC forms only when prescribed as monotherapy (Simulation 2). A costbenefit analysis was conducted based on these two simulations, from the hospital's perspective, for Normandy's population over a 1-year timeframe. Results: In Simulation 1, there was an average cost-saving of euro12 per patient per year, but it resulted in a loss of 10140 min, equivalent to 10 min per patient per year when compared to the current situation. Simulation 2 yielded average cost-savings for the hospital amounting to euro51 per patient per year, along with a time-saving of 67 min per patient per year compared to the current situation. Conclusions: The development of a program aimed at optimizing the prescription of Trastuzumab holds the potential to deliver significant cost-savings to hospitals while enhancing the quality of service provided to the patients. This optimization involves using H SC in monotherapy and BS IV in combination therapy administration.

7 February 2025 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
EBEric BARAT
Eric BARAT
EDElisa Dubec
Elisa Dubec
JRJohanna Raymond
Johanna Raymond
LJLuc-Marie Joly
Luc-Marie Joly
RLRomain Léguillon
Romain Léguillon
RVRémi Varin
Rémi Varin

31 January 2025 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
TCThibault Cousin
Thibault Cousin
FCFrédéric Chantreuil
Frédéric Chantreuil
EBEric BARAT
Eric BARAT
OBOlivier Boyer
Olivier Boyer
FNFrançoise Norol
Françoise Norol
CGCamille Giverne
Camille Giverne